Combined Orbital and Cranial Vessel Wall Magnetic Resonance Imaging for the Assessment of Disease Activity in Giant Cell Arteritis.

Autor:	Rhee, Rennie L., Rebello, Ryan, Tamhankar, Madhura A., Banerjee, Shubhasree, Liu, Fang, Cao, Quy, Kurtz, Robert, Baker, Joshua F., Fan, Zhaoyang, Bhatt, Vatsal, Amudala, Naomi, Chou, Sherry, Liang, Rui, Sanchez, Marisa, Burke, Morgan, Desiderio, Lisa, Loevner, Laurie A., Morris, Jeffrey S., Merkel, Peter A., Song, Jae W.
Předmět:	PREDICTIVE tests VISION disorders DIAGNOSTIC imaging RECEIVER operating characteristic curves DATA analysis RESEARCH funding FISHER exact test GIANT cell arteritis MAGNETIC resonance imaging DESCRIPTIVE statistics MANN Whitney U Test ORBITAL diseases DATA analysis software CRANIAL nerve diseases SENSITIVITY & specificity (Statistics) DISEASE risk factors DISEASE complications
Zdroj:	ACR Open Rheumatology; Apr2024, Vol. 6 Issue 4, p189-200, 12p
Abstrakt:	Objective: Acute visual impairment is the most feared complication of giant cell arteritis (GCA) but is challenging to predict. Magnetic resonance imaging (MRI) evaluates orbital pathology not visualized by an ophthalmologic examination. This study combined orbital and cranial vessel wall MRI to assess both orbital and cranial disease activity in patients with GCA, including patients without visual symptoms. Methods: Patients with suspected active GCA who underwent orbital and cranial vessel wall MRI were included. In 14 patients, repeat imaging over 12 months assessed sensitivity to change. Clinical diagnosis of ocular or nonocular GCA was determined by a rheumatologist and/or ophthalmologist. A radiologist masked to clinical data scored MRI enhancement of structures. Results: Sixty‐four patients with suspected GCA were included: 25 (39%) received a clinical diagnosis of GCA, including 12 (19%) with ocular GCA. Orbital MRI enhancement was observed in 83% of patients with ocular GCA, 38% of patients with nonocular GCA, and 5% of patients with non‐GCA. MRI had strong diagnostic performance for both any GCA and ocular GCA. Combining MRI with a funduscopic examination reached 100% sensitivity for ocular GCA. MRI enhancement significantly decreased after treatment (P < 0.01). Conclusion: In GCA, MRI is a sensitive tool that comprehensively evaluates multiple cranial structures, including the orbits, which are the most concerning site of pathology. Orbital enhancement in patients without visual symptoms suggests that MRI may detect at‐risk subclinical ocular disease in GCA. MRI scores decreased following treatment, suggesting scores reflect inflammation. Future studies are needed to determine if MRI can identify patients at low risk for blindness who may receive less glucocorticoid therapy. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text